Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 175 | 173 | 112 | 28 | 29 |
Gross Profit | 175 | 173 | 112 | 28 | 29 |
Operating Expenses | 2,102 | 1,820 | 1,667 | 772 | 1,469 |
Operating Income | -1,927 | -1,647 | -1,555 | -744 | -1,440 |
Pre-tax Income | -1,927 | -1,647 | -1,555 | -744 | -1,440 |
Net Income Continuous | -1,927 | -1,647 | -1,555 | -744 | -1,440 |
Net Income | $-1,927 | $-1,647 | $-1,555 | $-744 | $-1,440 |
EPS Basic Total Ops | -0.76 | -0.64 | -0.76 | -0.56 | -1.16 |
EPS Basic Continuous Ops | -0.76 | -0.65 | -0.75 | -0.58 | -1.15 |
EPS Diluted Total Ops | -0.76 | -0.64 | -0.76 | -0.56 | -1.16 |
EPS Diluted Continuous Ops | -0.76 | -0.65 | -0.75 | -0.58 | -1.15 |
EBITDA(a) | $-1,925 | $-1,645 | $-1,554 | $-743 | $-1,437 |